<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40450304</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1601-5223</ISSN><JournalIssue CitedMedium="Internet"><Volume>162</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>Hereditas</Title><ISOAbbreviation>Hereditas</ISOAbbreviation></Journal><ArticleTitle>Identification of EPHB4 as a potential causal gene and therapeutic target for endometriosis using Mendelian randomization.</ArticleTitle><Pagination><StartPage>92</StartPage><MedlinePgn>92</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s41065-025-00457-w</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Endometriosis is a common condition among women, characterized by chronic pain and infertility, presenting significant challenges for clinicians. This study aims to identify potential druggable targets to offer new therapeutic approaches.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We utilized the summary-data-based Mendelian randomization (SMR) method to investigate the causal relationships between druggable genes that encode plasma proteins and endometriosis. The data sources included the deCODE database, the UKB-PPP, and the FinnGen database. Colocalization analysis was used to identify whether candidate genes and the disease share a common causal genetic variant. Finally, we measured the protein abundance and relative mRNA expression levels of targeted druggable genes in the plasma and peripheral blood mononuclear cells (PBMCs) of endometriosis patients using ELISA and RT-qPCR.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">By integrating the results of SMR and colocalization analyses, we found that EPHB4 is strongly associated with the risk of endometriosis, with higher levels of EPHB4 correlating with an increased risk of the condition (P<sub>FDR</sub> &lt; 0.05, PPH4&#x2009;=&#x2009;0.99). RSPO3 is moderately associated, with higher levels of RSPO3 correlating with an increased risk of endometriosis (P<sub>FDR</sub> &lt; 0.001, PPH4&#x2009;=&#x2009;0.78). CD109, SAA1, SAA2, FSHB, and SEZ6L2 are weakly associated with endometriosis, with higher levels of FSHB and SEZ6L2 correlating with an increased risk of endometriosis, and higher levels of CD109, SAA1, and SAA2 correlating with a decreased risk of endometriosis (P<sub>FDR</sub> &lt; 0.05, PPH4&#x2009;&lt;&#x2009;0.6). ELISA and RT-qPCR analyses showed that the EPHB4 protein abundance in plasma and mRNA expression levels in PBMCs were significantly higher in the endometriosis group compared to the control group (P-value&#x2009;&lt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found that the druggable genes EPHB4, CD109, SAA1, SAA2, FSHB, and SEZ6L2 may be associated with the pathogenesis of endometriosis and are potential therapeutic targets for drug treatment. However, this preliminary study is limited by sample size and population diversity, requiring further validation to confirm the reliability of these findings.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ling</LastName><ForeName>Shaohua</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Baise People's Hospital/Affiliated Southwest Hospital of Youjiang Medical University for Nationalities, Baise, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xie</LastName><ForeName>Delong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinical Laboratory, Baise People's Hospital/Affiliated Southwest Hospital of Youjiang Medical University for Nationalities, Baise, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Lifang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Siqi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Gynecology, Baise People's Hospital/Affiliated Southwest Hospital of Youjiang Medical University for Nationalities, Baise, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Chun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Liying</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Baise People's Hospital/Affiliated Southwest Hospital of Youjiang Medical University for Nationalities, Baise, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Baise People's Hospital/Affiliated Southwest Hospital of Youjiang Medical University for Nationalities, Baise, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China. qinlimy@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Baise People's Hospital/Affiliated Southwest Hospital of Youjiang Medical University for Nationalities, Baise, China. qinxiaomy@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2019GXNSFBA245020</GrantID><Agency>the 2019 Natural Science Foundation of Guangxi, China</Agency><Country/></Grant><Grant><GrantID>Y20196316</GrantID><Agency>the High-Level Talent Scientific Research Project of the Affiliated Hospital of Youjiang Medical University for Nationalities, China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hereditas</MedlineTA><NlmUniqueID>0374654</NlmUniqueID><ISSNLinking>0018-0661</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EPHB4</Keyword><Keyword MajorTopicYN="N">Colocalization analysis</Keyword><Keyword MajorTopicYN="N">Druggable genome</Keyword><Keyword MajorTopicYN="N">Endometriosis</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: This study adhered to the principles of the Helsinki Declaration. It was approved by the Ethics Committee of Youjiang Medical University for Nationalities (Approval No. YYFYY-LL-2022-61, dated 9/9/2022) and all participants provided written informed consent. Competing interests: The authors declare no competing interests. Conflict of interest: Not applicable. Clinical trial number: Not applicable. Conflict of interest: The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>31</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40450304</ArticleId><ArticleId IdType="doi">10.1186/s41065-025-00457-w</ArticleId><ArticleId IdType="pii">10.1186/s41065-025-00457-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations[J]. Lancet. 2021;397(10276):839&#x2013;52. https://doi.org/10.1016/S0140-6736(21)00389-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00389-5</ArticleId><ArticleId IdType="pubmed">33640070</ArticleId></ArticleIdList></Reference><Reference><Citation>Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis[J]. BMJ. 2022;e070750. https://doi.org/10.1136/bmj-2022-070750 .</Citation></Reference><Reference><Citation>Mechsner S. Endometriosis, an ongoing pain&#x2014;step-by-step treatment[J]. J Clin Med. 2022;11(2):467. https://doi.org/10.3390/jcm11020467 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020467</ArticleId><ArticleId IdType="pubmed">35054161</ArticleId><ArticleId IdType="pmc">8780646</ArticleId></ArticleIdList></Reference><Reference><Citation>Scalia P, Maurancy J, Giordano A, et al. Transcriptional and post-translational control mechanisms for ephb4 expression in physiology and cancer disease[J]. Crit Rev Eukaryot Gene Expr. 2021;31(2):83&#x2013;8. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2021037928 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/CritRevEukaryotGeneExpr.2021037928</ArticleId><ArticleId IdType="pubmed">34347982</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Zhang H, Zhang Y. Targeting receptor tyrosine kinase ephb4 in cancer therapy[J]. Sem Cancer Biol. 2019;56:37&#x2013;46. https://doi.org/10.1016/j.semcancer.2017.10.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2017.10.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudzitis-Auth J, Fu&#xdf; SA, Becker V, et al. Inhibition of erythropoietin&#x2010;producing hepatoma receptor b4 (ephb4) signalling suppresses the vascularisation and growth of endometriotic lesions[J]. Br J Pharmacol. 2020;177(14):3225&#x2013;39. https://doi.org/10.1111/bph.15044 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15044</ArticleId><ArticleId IdType="pubmed">32144768</ArticleId><ArticleId IdType="pmc">7312277</ArticleId></ArticleIdList></Reference><Reference><Citation>Emdin CA, Khera AV, Kathiresan S. Mendelian randomization[J]. JAMA. 2017;318(19): 1925. https://doi.org/10.1001/jama.2017.17219</Citation></Reference><Reference><Citation>Chen J, Ruan X, Sun Y, et al. Multi-omic insight into the molecular networks of mitochondrial dysfunction in the pathogenesis of inflammatory bowel disease[J]. EBioMedicine. 2024;99:104934. https://doi.org/10.1016/j.ebiom.2023.104934 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104934</ArticleId><ArticleId IdType="pubmed">38103512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferkingstad E, Sulem P, Atlason BA, et al. Large-scale integration of the plasma proteome with genetics and disease[J]. Nat Genet. 2021;53(12):1712&#x2013;21. https://doi.org/10.1038/s41588-021-00978-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00978-w</ArticleId><ArticleId IdType="pubmed">34857953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun BB, Chiou J, Traylor M, et al. Plasma proteomic associations with genetics and health in the Uk biobank[J]. Nature. 2023;622(7982):329&#x2013;38. https://doi.org/10.1038/s41586-023-06592-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06592-6</ArticleId><ArticleId IdType="pubmed">37794186</ArticleId><ArticleId IdType="pmc">10567551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population[J]. Nature. 2023;613(7944):508&#x2013;18. https://doi.org/10.1038/s41586-022-05473-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05473-8</ArticleId><ArticleId IdType="pubmed">36653562</ArticleId><ArticleId IdType="pmc">9849126</ArticleId></ArticleIdList></Reference><Reference><Citation>Finan C, Gaulton A, Kruger FA, et al. The druggable genome and support for target identification and validation in drug development[J]. Sci Transl Med. 2017;9(383):eaag1166. https://doi.org/10.1126/scitranslmed.aag1166 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aag1166</ArticleId><ArticleId IdType="pubmed">28356508</ArticleId><ArticleId IdType="pmc">6321762</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Zhang F, Hu H, et al. Integration of summary data from Gwas and Eqtl studies predicts complex trait gene targets[J]. Nat Genet. 2016;48(5):481&#x2013;7. https://doi.org/10.1038/ng.3538 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3538</ArticleId><ArticleId IdType="pubmed">27019110</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics[J]. PLoS Genet. 2014;10(5):e1004383. https://doi.org/10.1371/journal.pgen.1004383 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004383</ArticleId><ArticleId IdType="pubmed">24830394</ArticleId><ArticleId IdType="pmc">4022491</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W-M, Gu X-J, Dou M, et al. Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer&#x2019;s disease[J]. J Neurol Neurosurg Psychiatry. 2023;94(11):954&#x2013;61. https://doi.org/10.1136/jnnp-2023-331142 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2023-331142</ArticleId><ArticleId IdType="pubmed">37349091</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Chen B, Qi Y, et al. Multi-omics Mendelian randomization integrating Gwas, Eqtl and Pqtl data revealed gstm4 as a potential drug target for migraine[J]. J Headache Pain. 2024;25(1):117. https://doi.org/10.1186/s10194-024-01828-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-024-01828-w</ArticleId><ArticleId IdType="pubmed">39039470</ArticleId><ArticleId IdType="pmc">11265128</ArticleId></ArticleIdList></Reference><Reference><Citation>Knox C, Wilson M, Klinger CM, et al. DrugBank 6.0: the drugbank knowledgebase for 2024[J]. Nucleic Acids Res. 2024;52(D1):D1265&#x2013;75. https://doi.org/10.1093/nar/gkad976 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkad976</ArticleId><ArticleId IdType="pubmed">37953279</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah DK, Correia KF, Vitonis AF, et al. Body size and endometriosis: results from 20 years of follow-up within the nurses&#x2019; health study Ii prospective cohort[J]. Hum Reprod. 2013;28(7):1783&#x2013;92. https://doi.org/10.1093/humrep/det120 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/det120</ArticleId><ArticleId IdType="pubmed">23674552</ArticleId><ArticleId IdType="pmc">3685336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong J, Yi KW. What is the link between endometriosis and adiposity?[J]. Obstet Gynecol Sci. 2022;65(3):227&#x2013;33. https://doi.org/10.5468/ogs.21343 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5468/ogs.21343</ArticleId><ArticleId IdType="pubmed">35081675</ArticleId><ArticleId IdType="pmc">9119730</ArticleId></ArticleIdList></Reference><Reference><Citation>Du E, Li X, He S, et al. The critical role of the interplays of ephrinb2/ephb4 and Vegf in the induction of angiogenesis[J]. Mol Biol Rep. 2020;47(6):4681&#x2013;90. https://doi.org/10.1007/s11033-020-05470-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05470-y</ArticleId><ArticleId IdType="pubmed">32488576</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MS, Han SJ. Endometriosis-associated angiogenesis and anti-angiogenic therapy for endometriosis[J]. Front Global Women&#x2019;s Health. 2022;3:856316. https://doi.org/10.3389/fgwh.2022.856316 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgwh.2022.856316</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubrzycka A, Zubrzycki M, Perdas E, et al. Genetic, epigenetic, and steroidogenic modulation mechanisms in endometriosis[J]. J Clin Med. 2020;9(5):1309. https://doi.org/10.3390/jcm9051309 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9051309</ArticleId><ArticleId IdType="pubmed">32370117</ArticleId><ArticleId IdType="pmc">7291215</ArticleId></ArticleIdList></Reference><Reference><Citation>Laschke MW, Menger MD. Basic mechanisms of vascularization in endometriosis and their clinical implications[J]. Hum Reprod Update. 2018;24(2):207&#x2013;24. https://doi.org/10.1093/humupd/dmy001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humupd/dmy001</ArticleId><ArticleId IdType="pubmed">29377994</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerlikaya G, Balendran S, Pr&#xf6;stling K, et al. Comprehensive study of angiogenic factors in women with endometriosis compared to women without endometriosis[J]. Eur J Obstet Gynecol Reproductive Biology. 2016;204:88&#x2013;98. https://doi.org/10.1016/j.ejogrb.2016.07.500 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2016.07.500</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani S, Edwards AK, Thomas R, et al. Blocking of stromal cell-derived factor-1 reduces neoangiogenesis in human endometriosis lesions in a mouse model[J]. Am J Reprod Immunol. 2013:n/a-n/a. https://doi.org/10.1111/aji.12134 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aji.12134</ArticleId><ArticleId IdType="pubmed">23650939</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvucci O, De La Luz Sierra M, Martina JA, et al. EphB2 and ephb4 receptors forward signaling promotes sdf-1-induced endothelial cell chemotaxis and branching remodeling[J]. Blood. 2006;108(9):2914&#x2013;22. https://doi.org/10.1182/blood-2006-05-023341 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2006-05-023341</ArticleId><ArticleId IdType="pubmed">16840724</ArticleId><ArticleId IdType="pmc">1895526</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimova I, Hlushchuk R, Makanya A, et al. Inhibition of Notch signaling induces extensive intussusceptive neo-angiogenesis by recruitment of mononuclear cells[J]. Angiogenesis. 2013;16(4):921&#x2013;37. https://doi.org/10.1007/s10456-013-9366-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-013-9366-5</ArticleId><ArticleId IdType="pubmed">23881168</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslam MI, Abraham J, Mansoor A et al. PDGFR&#x3b2; reverses ephb4 signaling in alveolar rhabdomyosarcoma[J]. Proceedings of the National Academy of Sciences. 2014;111(17):6383&#x2013;6388. https://doi.org/10.1073/pnas.1403608111</Citation></Reference><Reference><Citation>Zhou Y, Zhang Y, Zhao D, et al. TTD: therapeutic target database describing target druggability information[J]. Nucleic Acids Res. 2024;52(D1):D1465&#x2013;77. https://doi.org/10.1093/nar/gkad751 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkad751</ArticleId><ArticleId IdType="pubmed">37713619</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Cearbhaill RE, Miller A, Soslow RA, et al. A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: Nrg oncology/gynecologic oncology group study 0283[J]. Gynecol Oncol. 2023;176:16&#x2013;24. https://doi.org/10.1016/j.ygyno.2023.06.021 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2023.06.021</ArticleId><ArticleId IdType="pubmed">37418832</ArticleId><ArticleId IdType="pmc">10529107</ArticleId></ArticleIdList></Reference><Reference><Citation>Das M, Padda SK, Frymoyer A, et al. A safety, tolerability, and Pharmacokinetic analysis of two phase i studies of multitargeted small molecule tyrosine kinase inhibitor xl647 with an intermittent and continuous dosing schedule in patients with advanced solid malignancies[J]. Cancer Chemother Pharmacol. 2018;82(3):541&#x2013;50. https://doi.org/10.1007/s00280-018-3646-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00280-018-3646-0</ArticleId><ArticleId IdType="pubmed">30030583</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietanza MC, Gadgeel SM, Dowlati A, et al. Phase Ii study of the multitargeted tyrosine kinase inhibitor xl647 in patients with non-small-cell lung cancer[J]. J Thorac Oncology: Official Publication Int Association Study Lung Cancer. 2012;7(5):856&#x2013;65. https://doi.org/10.1097/JTO.0b013e31824c943f .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JTO.0b013e31824c943f</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker CM, Beaudry P, Funakoshi T, et al. Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis[J]. Am J Pathol. 2011;178(4):1782&#x2013;91. https://doi.org/10.1016/j.ajpath.2010.12.037 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2010.12.037</ArticleId><ArticleId IdType="pubmed">21435458</ArticleId><ArticleId IdType="pmc">3070089</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Liu D, Xu Q-F, et al. Endothelial rspo3 mediates pulmonary endothelial regeneration by lgr4-dependent activation of &#x3b2;-catenin and Ilk signaling pathways after inflammatory vascular injury[J]. Int J Biol Macromol. 2024;269(Pt 2):131805. https://doi.org/10.1016/j.ijbiomac.2024.131805 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2024.131805</ArticleId><ArticleId IdType="pubmed">38677673</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J, Zhou T, Chen G, et al. Effect of exogenous hormone on r-spondin 2 (rspo2) and r-spondin 3 (rspo3) gene expression and embryo development in Chinese soft-shelled turtle (pelodiscus sinensis)[J]. Genes. 2023;14(7):1466. https://doi.org/10.3390/genes14071466 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes14071466</ArticleId><ArticleId IdType="pubmed">37510371</ArticleId><ArticleId IdType="pmc">10379378</ArticleId></ArticleIdList></Reference><Reference><Citation>Monnin N, Fattet AJ, Koscinski I. Endometriosis: update of pathophysiology, (epi) genetic and environmental involvement[J]. Biomedicines. 2023;11(3):978. https://doi.org/10.3390/biomedicines11030978 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11030978</ArticleId><ArticleId IdType="pubmed">36979957</ArticleId><ArticleId IdType="pmc">10046867</ArticleId></ArticleIdList></Reference><Reference><Citation>Batal A, Garousi S, Finnson KW, et al. CD109, a master regulator of inflammatory responses[J]. Front Immunol. 2025;15:1505008. https://doi.org/10.3389/fimmu.2024.1505008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1505008</ArticleId><ArticleId IdType="pubmed">39990858</ArticleId><ArticleId IdType="pmc">11842317</ArticleId></ArticleIdList></Reference><Reference><Citation>Vorstenbosch J, Gallant-Behm C, Trzeciak A, et al. Transgenic mice overexpressing CD 109 in the epidermis display decreased inflammation and granulation tissue and improved collagen architecture during wound healing[J]. Wound Repair Regeneration. 2013;21(2):235&#x2013;46. https://doi.org/10.1111/wrr.12023 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/wrr.12023</ArticleId><ArticleId IdType="pubmed">23438099</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomini E, Minetto S, Li Piani L, et al. Genetics and inflammation in endometriosis: improving knowledge for development of new Pharmacological strategies[J]. Int J Mol Sci. 2021;22(16):9033. https://doi.org/10.3390/ijms22169033 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22169033</ArticleId><ArticleId IdType="pubmed">34445738</ArticleId><ArticleId IdType="pmc">8396487</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Ye RD. Serum amyloid a1: structure, function and gene polymorphism[J]. Gene. 2016;583(1):48&#x2013;57. https://doi.org/10.1016/j.gene.2016.02.044 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2016.02.044</ArticleId><ArticleId IdType="pubmed">26945629</ArticleId><ArticleId IdType="pmc">5683722</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye RD, Sun L. Emerging functions of serum amyloid a in inflammation[J]. J Leukoc Biol. 2015;98(6):923&#x2013;9. https://doi.org/10.1189/jlb.3VMR0315-080R .</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.3VMR0315-080R</ArticleId><ArticleId IdType="pubmed">26130702</ArticleId><ArticleId IdType="pmc">6608020</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigorova M, Rull K, Laan M. Haplotype structure of fshb, the beta-subunit gene for fertility&#x2010;associated follicle&#x2010;stimulating hormone: possible influence of balancing selection[J]. Ann Hum Genet. 2007;71(1):18&#x2013;28. https://doi.org/10.1111/j.1469-1809.2006.00299.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-1809.2006.00299.x</ArticleId><ArticleId IdType="pubmed">17227474</ArticleId><ArticleId IdType="pmc">1859982</ArticleId></ArticleIdList></Reference><Reference><Citation>Matalliotakis M, Zervou MI, Matalliotaki C, et al. The role of gene polymorphisms in endometriosis[J]. Mol Med Rep. 2017;16(5):5881&#x2013;6. https://doi.org/10.3892/mmr.2017.7398 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.7398</ArticleId><ArticleId IdType="pubmed">28901453</ArticleId><ArticleId IdType="pmc">5865763</ArticleId></ArticleIdList></Reference><Reference><Citation>Golovchenko I, Aizikovich B, Golovchenko O, et al. Sex hormone candidate gene polymorphisms are associated with endometriosis[J]. Int J Mol Sci. 2022;23(22):13691. https://doi.org/10.3390/ijms232213691 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232213691</ArticleId><ArticleId IdType="pubmed">36430184</ArticleId><ArticleId IdType="pmc">9697627</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao T, Mo X, Zhao L. Identifying novel potential drug targets for endometriosis via plasma proteome screening[J]. Front Endocrinol. 2024;15:1416978. https://doi.org/10.3389/fendo.2024.1416978 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2024.1416978</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>